Sebastian Maier

#Medizin @LMU_Muenchen
#TeamLauber @LMU_RadOnc

[Sebastian Maier @SebastianHMaier]

New paper out: Postoperative fractionated stereotactic radiotherapy (25 Gy in 5 fractions) after complete resection of brain metastases showed durable local control and low symptomatic radiation necrosis. https://t.co/WSrFxsiTYL

#RadiationOncology #NeuroOncology #BrainMetastases

[giuseppe Minniti @gminniti2012]

Happy to announce that the LEGATO trial has now enrolled more than 230 patients, exceeding half of its recruitment target. The study remains actively open across many European centres.
#Glioblastoma #ClinicalTrials #HorizonEU
@EORTC
@SapienzaRoma
@MedUni_Wien

[Sebastian Maier @SebastianHMaier]

Thank you so much for highlighting our work @PDBrownOnc! #radonc

[PDBrown @PDBrownOnc]

Is 25Gy/5 to post-op cavity after resection brain met effective?
Yes, according to this study
~90% LC at 1 and 4 years
Symptomatic Radiation Necrosis 3%

[Max Niyazi @MaxNiyazi]

Biomarker Integration into Radiation Oncology clinical trials - A Thread

1/
Very pleased to see our work (Kolias et al., 2026) published in @RO_GreenJournal.

🔗 https://t.co/H2R5n7u85D

[giuseppe Minniti @gminniti2012]

Now on JAMA to confirm that SRS should be recommended for multiple BMs regardless the number of lesions to preserve QOL and neurocognition. More trials on SRS and systemic treatments need to optimize treatments.
@EANOassociation
@myESMO
@EORTC
@ESTRO_RT
@SapienzaRoma

[Sebastian Maier @SebastianHMaier]

🎉 Just published in #tipsRO: “Improved PTV coverage and OAR sparing with stereotactic MRI-guided online adaptive radiotherapy with elective fields in pancreatic cancer.” 👏🎯🧲 #RadiationTherapy #Oncology #PDAC #MRgRT @ESTRO_RT @LMU_RadOnc @PaulRogowski1 https://t.co/gFM4F4z1aa

[Sebastian Maier @SebastianHMaier]

New in Radiation Oncology 📢
SSTR PET/CT + MRI improves GTV delineation for skull base low-grade meningiomas vs. MRI alone-capturing bone invasion & subtle extensions, boosting interobserver agreement.
👉 https://t.co/YY5vrC6oCl
#RadOnc #NeuroOncology #PETCT @LMU_RadOnc #sbrt

[Sebastian Maier @SebastianHMaier]

CHAT-RT study: ChatGPT in radiation oncology-a survey on usage, perception, and impact among DEGRO members now out @BioMedCentral https://t.co/AYeh4M9BMu @LMU_RadOnc #DEGRO #ChatGPT #AI @degro_ev

[Sebastian Maier @SebastianHMaier]

🧠📚 Empowering patients through clear, reliable communication is crucial—and AI may help bridge the gap. @LMU_RadOnc #chatgo #ChatGPT #LLM

[Sebastian Maier @SebastianHMaier]

How can large language models support patient education for individuals diagnosed with meningioma? Our results highlight the potential of AI tools to complement the work of healthcare professionals by making complex medical information more understandable. https://t.co/axklRvcSv6

[giuseppe Minniti @gminniti2012]

Four CNS guidelined on RT for GBM, Spine, IDH-mut gliomas, and reirradiation are most read (last 30 days) on @RO_GreenJournal . Improving the quality of our treatments means better outcome and QOL for our pts
@ESTRO_RT
@EANOassociation
@MaxNiyazi
@Mat_Guc
@alongi_filippo

[Andreas Püttmann @Puettmann_Bonn]

Mein Gespräch mit @FJ_Murau von @zeitonline_kul über die Krise der liberalen Demokratie und deren vor allem rechtsextreme Feinde, über CDU/CSU und BSW sowie die Notwendigkeit demokratischer Eliten gibt es hier auch frei zugänglich: https://t.co/FrGjDpB8Ze

[Translational Radiobiology at UKER @translatradbio]

Good morning! Starting our last day with a basic knowledge talk from Nikko Brix 😄

[Barack Obama @BarackObama]

We’re fired up and ready to go! Let’s do all we can to elect @KamalaHarris and @Tim_Walz.

Join us: https://t.co/P9hoDak8Rn

[Max Niyazi @MaxNiyazi]

All you ever wanted to know about detailed FET PET delineation in glioblastoma with a lots of practical guidance and typical pitfalls #radonc - thank you so much to the fantastic team @SebastianHMaier @ProfNAlbert @dr_clafougere @R_Bodensohn @gminniti2012 @galldiks

[Sebastian Maier @SebastianHMaier]

Hot Off the Press: FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls https://t.co/P0y7CXvV5r #pridetrial #greenjournal @R_Bodensohn @MaxNiyazi @ProfNAlbert @SebastianMarsc1 @RadiotherapyOn1

[Sebastian Maier @SebastianHMaier]

@Puettmann_Bonn @KASonline Alles Gute zum Geburtstag 🎉

[Sebastian Maier @SebastianHMaier]

Very excited to be able to share our dummy run paper for the now open #PRIDE study - #ProKnow plan comparison for quality assurance. Thank you so much for the fantastic collaboration! Just in time for #ESTRO24. #glioblastoma https://t.co/HuaRznaFoi @MaxNiyazi @R_Bodensohn

[Sebastian Maier @SebastianHMaier]

Revolutionising SRS/SRT: @MaxNiyazi on the use of MR-Linac in brain metastases. @ESTRO_RT #ESTRO24

[Raphael Bodensohn @R_Bodensohn]

Now hearing the @ESTRO_RT @EANOassociation joint meeting at #ESTRO2024 on #radiosurgery of #brain_metastases moderated by @MaxNiyazi from @UKT_RadOnc